Omega Protein


Omega Protein Reports 7 Cents Per Share Third Quarter Profit

HOUSTON, October 29, 2004 - Omega Protein Corporation (NYSE symbol: OME), the nation's leading producer of fish oil rich in Omega-3 fatty acids and specialty fish meal products, today reported net income of $1.8 million (7 cents a share) for the third quarter of 2004, compared with net income of $740,000 (3 cents a share) for the third quarter of the previous year.

Revenues for the third quarter ended September 30, 2004 were $41.5 million compared with revenues of $32.2 million for the comparable quarter of 2003. Omega Protein reported gross profit of $5.1 million for the 2004 third quarter, versus gross profit of $3.6 million for the third quarter of 2003.

For the nine months ended September 30, 2004, the Company had revenues of $93.0 million, compared with $84.5 million in revenues for the first nine months of 2003. Omega Protein reported gross profit of $14.2 million for the nine-month period in 2004, versus gross profit of $16.2 million for the comparable period a year earlier. The Company had net income of $4.3 million (18 cents a share) for the 2004 nine-month period, compared with net income of $5.8 million (24 cents a share) for the first nine months of 2003.

Omega Protein's third quarter results, as well as the results for the nine months ended September 30, 2004, reflect reduced margins due to less than expected fish catch in the Gulf of Mexico caused by adverse weather conditions. The reduced fish catch results in higher cost inventories and correspondingly higher cost of sales, as well as less product available for future sales.


Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.


Special Note Regarding Forward-Looking Statements: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward -looking statements include, among others, (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; and (3) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its 2002 Annual Report on Form 10K under the headings, Management's Discussion and Analysis of Financial Condition and Results of Operations Significant Factors That May Affect Forward-Looking Statements and Seasonality and Quarterly Results.

Contact: Investor Relations Department (713) 623-0060 or news@omegahouston.com


OMEGA PROTEIN CORPORATION
Statement of Operations>
(Unaudited)
 
  Three Months
Ended September 30,
Nine Months
Ended September 30,
  2004 2003 2004 2003
  (in thousands, except per share amounts)
Revenues $41,501 $32,151 $93,013 $84,544
Cost of sales 36,376 28,553 78,821 68,346
Gross profit 5,125 3,598 14,192 16,198
Selling, general, and
administrative expense
2,425 2,232 7,305 6,711
Operating income 2,700 1,366 6,887 9,487
Interest income (expense), net 82 (178) (289) (497)
Other expense, net (55) (12) (161) (42)
Income before income taxes 2,727 1,176 6,437 8,948
Provision for income taxes 911 436 2,148 3,181
Net income $1,816 $740 $4,289 $5,767
Basic earnings per share $0.07 $0.03 $0.18 $0.24
Average common shares outstanding 24,517 24,279 24,451 24,129
Diluted earnings per share $0.07 $0.03 $0.16 $0.22
Average common shares and
common share equivalents outstanding
26,466 25,982 26,439 25,692



OMEGA PROTEIN CORPORATION
CONDENSED BALANCE SHEET
(Unaudited)

  September 30, 2004 December  31, 2003
  (in thousands)
ASSETS    
Current assets $96,783 $97,445
Property and equipment, net 97,029 85,231
Deferred tax assets, net 536 405
Other assets 2,108 3,087
   Total Assets $196,456 $186,168
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities $22,166 $16,508
Long-term debt, less current maturities 16,367 17,605
Other long-term liabilities 7,359 6,838
Stockhoders' equity 150,564 145,217
   Total liabilities and stockholders' equity $196,456 $186,168



  Omega Protein Corporation, Inc. All rights reserved.